Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr 28;38(7):767-771.
doi: 10.1515/jpem-2025-0103. Print 2025 Jul 28.

Emergence of osteolysis as a new radiological feature in a case with a novel BMP2 gene variant

Suzan Süncak  1 , Merve Berfin Aktan Karaca  2 , Semra Gürsoy  1 , Mehmet Kocabey  2 , Korcan Demir  3 , Fatma Ceren Sarıoğlu  4 , Ayfer Ülgenalp  2 , Özlem Giray Bozkaya  1
Affiliations
Case Reports

Emergence of osteolysis as a new radiological feature in a case with a novel BMP2 gene variant

Suzan Süncak et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Bone morphogenetic protein 2 (BMP2) is essential for endochondral ossification, skeletal development, and bone homeostasis. Monoallelic loss-of-function variants in BMP2 have been linked to short stature, facial dysmorphism, and skeletal anomalies, often accompanied by cardiac involvement. Here, we describe a 10-year-old girl with a novel heterozygous truncating BMP2 variant, presenting with distinct facial features, short stature, and skeletal abnormalities, notably osteolysis in the phalanges.

Case presentation: The patient was initially evaluated at six months of age due to hypotonia and dysmorphic facial features. At 10 years old, she presented with short stature and skeletal radiographs revealed osteolysis in multiple phalanges. Additional clinical evaluations, including echocardiography and metabolic studies, were unremarkable. Whole-exome sequencing identified a de novo heterozygous truncating variant (c.440C>G; p.Ser147*) in BMP2.

Conclusions: This report identifies a novel BMP2 nonsense variant and introduces osteolysis as a previously unrecognized phenotype. These findings highlight the necessity of longitudinal skeletal monitoring in BMP2-related conditions and underscore the importance of genetic evaluation in patients with subtle skeletal dysplasias to facilitate early diagnosis and management.

Keywords: BMP2 gene; SSFSC1; osteolysis; short stature; skeletal dysplasia.

PubMed Disclaimer

References

    1. Miyazono, K, Kamiya, Y, Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010;147:35–51. https://doi.org/10.1093/jb/mvp148 . - DOI
    1. Wang, RN, Green, J, Wang, Z, Deng, Y, Qiao, M, Peabody, M, et al.. Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis 2014;1:87–105. https://doi.org/10.1016/j.gendis.2014.07.005 . - DOI
    1. Mueller, TD, Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett 2012;586:1846e1859. https://doi.org/10.1016/j.febslet.2012.02.043 . - DOI
    1. Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, ACMG Laboratory Quality Assurance Committee , et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 2015;17:405–24. https://doi.org/10.1038/gim.2015.30 . - DOI
    1. Heubel, B, Nohe, A. The role of BMP signaling in osteoclast regulation. J Dev Biol 2021;9:24. https://doi.org/10.3390/jdb9030024 . - DOI

Publication types

Substances